Scholars Funded by IRACDA
Eric Figueroa, PhD
Pharmacology,
Vanderbilt University
Dr. Eric Figueroa is a postdoctoral scholar in Dr. David Julius’ lab in the Department of Physiology. Dr. Figueroa’s research is focused on studying the molecular and cellular physiology of enterochromaffin (EC) cells, specialized sensory cells in the gut. The goal is to understand how EC cells sense the gut's environment and contribute to visceral pain. (Appointed to IRACDA August 2021, funded by T32DK007418 July 2023-July 2026, IRACDA August 2026-present)
Ximena Garcia Arceo, PhD
Biochemistry and Molecular Biophysics,
University of California, San Diego
Dr. Ximena Garcia Arceo is a postdoctoral scholar in Wallace Marshall's group in the Department of Biochemistry and Biophysics. Dr. Arceo is characterizing the role and origin of gene expression noise in the proliferation, viability, and responsiveness of endothelial cells as they age. The goal is to understand the emergence of various senescent phenotypes in endothelial cells, whose progressive loss of plasticity is implicated in cardiovascular disease. (Appointed to IRACDA February 2024).
Emily Lam, PhD
Integrative Biology,
University of California, Berkeley
Dr. Emily Lam is a postdoctoral scholar in Dr. Diana Laird’s lab in the Department of Obstetrics, Gynecology, Center for Reproductive Sciences and Institute of Regeneration Medicine. She is using primary cell culture and stem cell technologies to study the mechanisms regulating reproductive activation in the eusocial naked mole-rat. Her research aims to characterize phenotypic differences between subordinates and queens, which may reveal natural mechanisms that enable an extended reproductive lifespan without a decline in fecundity in this emerging model organism. (Appointed August 2025)
Haley Mendoza-Romero, PhD
Molecular Physiology and Biophysics,
Vanderbilt University
Dr. Haley Mendoza-Romero is a postdoctoral scholar in Dr. Martin Valdearcos' lab in the Diabetes Center. Dr. Mendoza-Romero is interested in understanding how environmental influences during sensitive periods of development contribute to changes at the cellular level in the central nervous system. She is currently investigating how high fat diet exposure during the lactation period in mice influences the activity of glial cells and neurons in discrete nuclei of the hypothalamus. Investigating the interactions between neurons and glia during this period of postnatal development of offspring is critical to understand how neural circuits that control food intake are established and ultimately how they can drive changes in feeding behavior and metabolic phenotype into adulthood. (Appointed to IRACDA August 2025)
Jonathan Meng, PhD
Chemistry,
University of Cambridge
Dr. Jonathan Meng is a postdoctoral scholar in Dr. Ken Nakamura's lab in the Department of Neurology/Gladstone Institutes. Dr. Jonathan Meng is interested in understanding the functions of mitochondrial bioenergetics and dynamics in human neurons and how disrupting these mitochondrial functions in turn contributes to neurodegenerative diseases, especially PD and AD. (Appointed to IRACDA December 2023-December 2026)
Sarah Mohr, PhD
Neuroscience,
Yale University
Dr. Sarah Mohr is a postdoctoral scholar working with Dr. Holly Ingraham in the Department of Cellular and Molecular Pharmacology. Dr. Mohr is interested in how the brain and body communicate to coordinate the dynamic physiological transformations of pregnancy. Her goal is to understand how the brain regulates maternal cardiovascular adaptations. Ultimately, this work will identify brain regions that may be leveraged as targets to treat cardiovascular disorders and complications of pregnancy. (Appointed to IRACDA August 2025)
Hannah Nilsson, PhD
Cell and Molecular Biology,
University of California, Berkeley
Dr. Nilsson is a postdoctoral scholar in Dr. Zaro's Lab in the Department of Pharmaceutical Chemistry. Dr. Nilsson's research is currently focused on redeployment of microbial proteins in macrophages during infection. The goal of the study is to better understand how macrophages are able to coordinate and respond to a diverse array of environments and inputs as they toggle between homeostatic and inflammatory states and how these processes can be coopted by pathogens. (Appointed to IRACDA October 2026)
Shea Ricketts, PhD
Pathobiology and Translational Science,
University of North Carolina, Chapel Hill
Dr. Ricketts is a postdoctoral scholar in Dr. Vedantham's lab in the Department of Medicine. Dr. Ricketts' research is currently focused on investigating the gene regulatory mechanisms underlying heart rhythm dynamics and cardiac adaptation or dysfunction during pregnancy, a period of heightened cardiovascular vulnerability that are not understood. (Appointed to IRACDA August 2026)
Priscilla Tjandra, PhD
Biomedical Engineering,
University of California, Davis
Dr. Tjandra is a postdoctoral scholar in the Dr. Collin’s lab in the Department of Orthopaedic Surgery. Dr. Tjandra is interested in investigating the relationship between fat tissue, pain, and structural damage in knee osteoarthritis. Her goal is to identify novel therapeutic targets for this chronic disease towards a far-reaching, inclusive population. (Appointed to IRACDA August 2024)
Zsófia Török, PhD
Neurobiology,
California Institute of Technology
Dr. Zsófia Török is a postdoctoral scholar in Dr. Holly Ingraham’s lab in the Department of Cellular and Molecular Pharmacology at the University of California, San Francisco (UCSF). Dr. Török’s research focuses on understanding how hypothalamic neural circuits coordinate metabolic adaptations and maintain glucose homeostasis during pregnancy. Her work aims to uncover the neural mechanisms that support maternal metabolic health and identify potential therapeutic targets for gestational diabetes and other pregnancy-related metabolic disorders. (Appointed to IRACDA August 2026)
Regan Volk, PhD
Biochemistry,
University of California, San Francisco
Dr. Volk is a postdoctoral scholar in Dr. Zaro's lab in the Department of Pharmaceutical Chemistry. Dr. Volk's research is currently focused on evaluating candidate small molecules targeting G proteins as a treatment for Uveal Melanoma. It is estimated that only half of Uveal Melanoma cases are treatable, but the other half experience metastasis and relapse. Dr. Volk's research aims to answer those questions. (Appointed to IRACDA August 2025)
Associated Scholars
Mor Alkaslasi, PhD
Neuroscience,
Brown University Graduate Program at the National Institutes of Health
Dr. Mor Alkaslasi is a postdoctoral scholar in Dr. Martin Kampmann's lab in the Institute for Neurodegenerative Diseases. Dr. Alkaslasi is interested in understanding the molecular mechanisms driving selective vulnerability in neurodegeneration. Across neurodegenerative conditions, certain neuronal subtypes are more vulnerable to pathology and death, such as cortical and hippocampal neurons in Alzheimer's disease and spinal motor neurons in ALS. Identifying the molecular drivers of this phenomenon will be important for developing therapeutic interventions. (Appointed to IRACDA August 2024-July 2025, Hillbloom Fellowship August 2025-present).
Lucas E. Cabrera-Zapata, PhD
Biology,
Universidad Nacional de Córdoba, Argentina
Dr. Lucas Cabrera-Zapata is a postdoctoral scholar in Dr. Ingraham's Lab in the Department of Cellular and Molecular Pharmacology. Dr. Cabrera-Zapata's research is currently focused on studying how estrogen-sensitive neuronal projections from the hypothalamus modulate the function of the pons to affect overall arousal. We are particularly interested in understanding sex differences in how estrogen signaling engages hypothalamic-pontine neural circuits to regulate energy expenditure, physical activity, and arousal. (Appointed to IRACDA SOM Dean's Funding November 2023-July 2026)
Nicole Fisher, PhD
Pharmacology,
Vanderbilt University
Dr. Nicole Fisher is a postdoctoral scholar in the lab of Dr. Mark von Zastrow in the Department of Psychiatry. Dr. Fisher’s research focuses on G protein-coupled receptors (GPCRs), a class of cell surface proteins that initiate signaling and serve as targets for many drugs. Dr. Fisher is particularly interested in understanding how GPCR signaling is organized and regulated within neurons. (Appointed to IRACDA August 2021-July 2024, NIDA K01 Award, June 2026-present)
Alex Ritter, PhD
Biomolecular Engineering,
University of California, Santa Cruz
Dr. Ritter is a postdoctoral scholar in Dr. Zikherman’s lab in the Department of Medicine, Rheumatology. Dr. Ritter is interested in the underlying mechanisms that drive inappropriate adaptive immune responses to autoantigens in autoimmune disease contexts. Dr. Ritter is studying B cell and T cell antigen receptor signaling and co-stimulation to identify points of vulnerability that potentiate breaches in tolerance. This work will pave the way for new and improved treatments for autoimmune diseases. (Appointed to IRACDA August 2024-May 2026, NIAID F32 Award June 2026-present)
Dania Zuniga, MS, PhD
Biochemistry and Molecular Biology,
Sorbonne University
Dr. Dania Zuniga is a postdoctoral scholar in Dr. Daniel Minor’s lab in the Department of Cardiovascular Research Institute. Dr. Zuniga works on the biochemical and structural characterization of ion channels. In humans, when these channels are defective, they lead to many diseases. Dr. Zuniga is interested in understanding the ion channel action mechanisms, ligand interactions and regulation, and how certain pathogenic mutations cause dysfunction. (Appointed to IRACDA August 2023-June 2025, T32 July 2025-June 2026, PI Funding July 2026-present).